Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Good

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
Annual Review of Immunology|March 18, 2005
Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine researchMichael F Good, Huji Xu, Michelle Wykes, et al.
Expert Review of Vaccines|October 21, 2015
Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococciMichael F Good, Manisha Pandey, Michael R Batzloff, et al.
Immunological Reviews|September 14, 2004
The immunological challenge to developing a vaccine to the blood stages of malaria parasitesMichael F Good, Danielle Stanisic, Huji Xu, et al.
BMC Microbiology|October 18, 2005
M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysisNonglak Yoonim, Colleen Olive, Chulabhorn Pruksachatkunakorn, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
In vivo efficacy of a chimeric peptide derived from the conserved region of the M protein against group C and G streptococciTherese Nordström, Jessica Malcolm, Graham Magor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Plasmodium yoelii can ablate vaccine-induced long-term protection in miceMichelle N Wykes, Yong-Hong Zhou, Xue Q Liu, et al.
FEMS Immunology and Medical Microbiology|March 25, 2004
Immune response to superoxide dismutase in group A streptococcal infectionDavid J McMillan, Mark R Davies, Michael F Good, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodiesDanielle I Stanisic, Laura B Martin, Michelle L Gatton, et al.
Vaccines|July 26, 2020
Generation of a Peptide Vaccine Candidate against Falciparum Placental Malaria Based on a Discontinuous EpitopeCatherine J Mitran, Lauren M Higa, Michael F Good, et al.
Immunology and Cell Biology|April 10, 2002
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technologyWendy A Hayman, Istvan Toth, Nicholas Flinn, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
Annual Review of Immunology|March 18, 2005
Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine researchMichael F Good, Huji Xu, Michelle Wykes, et al.
Expert Review of Vaccines|October 21, 2015
Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococciMichael F Good, Manisha Pandey, Michael R Batzloff, et al.
Immunological Reviews|September 14, 2004
The immunological challenge to developing a vaccine to the blood stages of malaria parasitesMichael F Good, Danielle Stanisic, Huji Xu, et al.
BMC Microbiology|October 18, 2005
M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysisNonglak Yoonim, Colleen Olive, Chulabhorn Pruksachatkunakorn, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2012
In vivo efficacy of a chimeric peptide derived from the conserved region of the M protein against group C and G streptococciTherese Nordström, Jessica Malcolm, Graham Magor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Plasmodium yoelii can ablate vaccine-induced long-term protection in miceMichelle N Wykes, Yong-Hong Zhou, Xue Q Liu, et al.
FEMS Immunology and Medical Microbiology|March 25, 2004
Immune response to superoxide dismutase in group A streptococcal infectionDavid J McMillan, Mark R Davies, Michael F Good, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodiesDanielle I Stanisic, Laura B Martin, Michelle L Gatton, et al.
Vaccines|July 26, 2020
Generation of a Peptide Vaccine Candidate against Falciparum Placental Malaria Based on a Discontinuous EpitopeCatherine J Mitran, Lauren M Higa, Michael F Good, et al.
Immunology and Cell Biology|April 10, 2002
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technologyWendy A Hayman, Istvan Toth, Nicholas Flinn, et al.
Pageof 22